Zinevich, T.V.; Maslov, I.O.; Kirichenko, O.G.; Shorshnev, S.V.; Gureev, M.A.; Dolgushin, F.M.; Porozov, Y.B.; Trukhan, V.M.
3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals 2025, 18, 642.
https://doi.org/10.3390/ph18050642
AMA Style
Zinevich TV, Maslov IO, Kirichenko OG, Shorshnev SV, Gureev MA, Dolgushin FM, Porozov YB, Trukhan VM.
3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals. 2025; 18(5):642.
https://doi.org/10.3390/ph18050642
Chicago/Turabian Style
Zinevich, Tatiana V., Ivan O. Maslov, Olga G. Kirichenko, Sergey V. Shorshnev, Maxim A. Gureev, Fedor M. Dolgushin, Yuri B. Porozov, and Vladimir M. Trukhan.
2025. "3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM" Pharmaceuticals 18, no. 5: 642.
https://doi.org/10.3390/ph18050642
APA Style
Zinevich, T. V., Maslov, I. O., Kirichenko, O. G., Shorshnev, S. V., Gureev, M. A., Dolgushin, F. M., Porozov, Y. B., & Trukhan, V. M.
(2025). 3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals, 18(5), 642.
https://doi.org/10.3390/ph18050642
